Company Filing History:
Years Active: 2005
Title: Mark Llewellyn Lewis: Innovator in Pharmaceutical Compounds
Introduction
Mark Llewellyn Lewis is a notable inventor based in Sandwich, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of therapeutic compounds. With a total of 2 patents to his name, Lewis continues to push the boundaries of innovation in medicine.
Latest Patents
Lewis's latest patents include groundbreaking work on quinazolinone compounds that are useful in therapy. These compounds are characterized by a specific formula (I) and include pharmaceutically acceptable salts or solvates thereof. Additionally, he has developed oxytocin inhibitors, which relate to compounds of formula (I). These inventions hold promise for advancing therapeutic options in various medical fields.
Career Highlights
Mark Llewellyn Lewis is currently associated with Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to collaborate with some of the brightest minds in the industry, contributing to the development of innovative therapies.
Collaborations
Throughout his career, Lewis has worked alongside esteemed colleagues such as Duncan Robert Armour and Andrew Simon Bell. These collaborations have fostered an environment of creativity and innovation, leading to the successful development of new pharmaceutical compounds.
Conclusion
Mark Llewellyn Lewis exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborations continue to impact the field positively.